News Hopes rise for new Alzheimer’s drug after secondary analysis BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h4048 (Published 24 July 2015) Cite this as: BMJ 2015;351:h4048 Article Related content Metrics Responses Peer review Related articles Views & Reviews Margaret McCartney: The “breakthrough” drug that’s not been shown to help in Alzheimer’s disease Published: 24 July 2015; BMJ 351 doi:10.1136/bmj.h4064 News Promise of new Alzheimer’s drug is dashed after lack of evidence Published: 24 November 2016; BMJ 355 doi:10.1136/bmj.i6362 News Sixty seconds on . . . solanezumab Published: 29 November 2016; BMJ 355 doi:10.1136/bmj.i6389 Personal viewMargaret McCartney: The “breakthrough” drug that’s not been shown to help in Alzheimer’s disease See more Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysis BMJ December 05, 2016, 355 i6188; DOI: https://doi.org/10.1136/bmj.i6188 NHS to fund large trial of pre-exposure prophylaxis for HIV prevention BMJ December 05, 2016, 355 i6537; DOI: https://doi.org/10.1136/bmj.i6537 Bill to boost medical research funding and speed drug approval passes US house BMJ December 01, 2016, 355 i6498; DOI: https://doi.org/10.1136/bmj.i6498 Alpha blockers for treatment of ureteric stones: systematic review and meta-analysis BMJ December 01, 2016, 355 i6112; DOI: https://doi.org/10.1136/bmj.i6112 Sixty seconds on . . . solanezumab BMJ November 29, 2016, 355 i6389; DOI: https://doi.org/10.1136/bmj.i6389 Cited by... Sixty seconds on . . . solanezumabFulltext PDF Promise of new Alzheimers drug is dashed after lack of evidenceFulltext PDF
